Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into weight loss injections in Newcastle, the two licensed options in the UK right now are Mounjaro (tirzepatide) and Wegovy (semaglutide) — both prescription-only medicines that require a clinical assessment before a prescriber can approve them. Neither is available over the counter, and geography doesn't change that rule. What does differ is how you access them: through the NHS, through a local private clinic, or through a regulated online pharmacy that can reach you wherever you live in the UK. This page lays out the decision honestly, so you can work out which route fits your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phrase covers two distinct medicines. Mounjaro, made by Eli Lilly, is a dual GIP and GLP-1 receptor agonist, it stimulates two separate gut-hormone pathways involved in appetite regulation and blood-sugar control. Wegovy, made by Novo Nordisk, targets the GLP-1 pathway alone. Both slow gastric emptying and reduce appetite, but they are not the same medicine, and the clinical trial results differ meaningfully. For a fuller comparison of what these medicines do and how they differ, our guide to weight loss injections covers the evidence in detail.
Treatment starts at a low dose in each case (2.5mg for Mounjaro, 0.25mg for Wegovy) and is titrated gradually by the prescriber. This staged approach exists because your digestive system needs time to adjust; the first pen's job is tolerability, not maximum effect. Both medicines are Black Triangle (▼) products, meaning the MHRA keeps additional watch on them as newer treatments. If you are weighing up your options, it is also worth reading about the three weight loss injections currently available in the UK, since the choice between them depends on your medical history and what your prescriber considers appropriate. The NHS medicines page for tirzepatide is a reliable starting point for understanding what the treatment involves before you speak to a prescriber.
One thing worth knowing: neither medicine is a standalone fix. Both are licensed alongside a reduced-calorie diet and increased physical activity. The injection handles appetite; the lifestyle piece handles what you do with that reduced hunger.
NHS access to these medicines is real but restricted. NICE recommended tirzepatide (Mounjaro) in December 2024 under strict criteria, currently adults with a BMI of 40 or above plus four or more of five specified conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes). A second cohort covering BMI 35–39.9 with four or more of those conditions opened in June 2026. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.
For Wegovy, NICE guidance (TA875) restricts NHS use to specialist weight management services, for a maximum of two years, with multidisciplinary support. Waiting lists for those services are commonly long across England, and Newcastle is no exception.
From April 2026, some GP practices can prescribe tirzepatide directly under the new GP contract, but participation is optional, and coverage varies by practice and by ICB area. The honest position is this: if you meet the NHS criteria, pursuing that route is worth doing; if you don't meet them yet, or the wait doesn't work for your situation, private prescription is the legal alternative. Recent news on how UK access is expanding gives a clearer picture of how quickly this is moving.
A regulated online pharmacy operating under a GPhC registration can prescribe and dispense to any UK address, including every postcode in Newcastle and the wider North East. You don't need to travel to a clinic. The consultation happens online; if clinically approved, the medicine ships the same day (for orders placed before midday) and arrives the next working day by tracked DPD in plain packaging. That cut-off at noon matters, if you get your paperwork in before lunch, you're not waiting over a weekend.
The thing that varies between private providers is what's actually included in the price. Some advertise a headline figure that excludes the consultation fee, the prescription, delivery, or ongoing clinical oversight. Understanding what weight loss injection prices actually include is worth doing before you commit anywhere. At nume, one transparent price covers the consultation, prescription, treatment, delivery, and priority aftercare seven days a week, no subscription, no auto-renewal, and every repeat order is clinically reviewed individually.
Verifying any online pharmacy before you hand over personal medical information is straightforward: check it on the GPhC pharmacy register. If it isn't listed, don't use it. You may also come across claims about lemon injections for weight loss, which is a term worth understanding so you can distinguish unlicensed or unproven substances from the regulated medicines discussed here. A registered pharmacy, a real prescriber, and a UK-licensed supply chain are what keep you safe.
Private licensed eligibility broadly follows the medicine's SmPC: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as prediabetes, hypertension, high cholesterol, or obstructive sleep apnoea. BMI alone never guarantees approval, the prescriber looks at the full picture, including your medical history and any medicines you're already taking.
The side-effect profile is GI-led: nausea, diarrhoea, constipation, indigestion, and fatigue are the most commonly reported, particularly after starting or after a dose increase. These typically ease within a couple of weeks. Seek urgent medical attention for severe, persistent stomach pain that spreads to the back, this can signal pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk. Women taking oral contraceptives should know that tirzepatide can temporarily reduce pill absorption; adding a barrier method for the first four weeks of treatment and four weeks after each dose increase is the recommended precaution per NHS guidance. If you have seen recent coverage about the new weight loss injection options entering the UK market, your prescriber can help you assess whether any of those are relevant to your situation. Suspected side effects can be reported at the MHRA's Yellow Card scheme.
If you want to understand what's available and how the clinical review works before committing, our treatment overview sets it all out clearly. Our clinical team reviews every consultation personally. When you're ready, starting a free consultation is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.